APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neonatal Immune Cell Storage Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Neonatal Immune Cell Storage Service Market Outlook and Growth Opportunities 2026

1 May 2026190 pages

Choose your research edition.

Industry ResearchNeonatal Immune Cell Storage Service Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Neonatal Immune Cell Storage Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Neonatal Immune Cell Storage Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neonatal Immune Cell Storage Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neonatal Immune Cell Storage Service Market Analysis and Forecast 2026-2032252 pages · $4,950 USD

Market perspective

The global Neonatal Immune Cell Storage Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neonatal Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neonatal Immune Cell Storage Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neonatal Immune Cell Storage Service market include Shanghai Cell Therapy Group, BGI Group, VCANBIO, CGT GLOBAL, Cordlife Group, ThermoGenesis, HealthBanks, BioLife Solutions and Sartorius, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Neonatal Immune Cell Storage Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neonatal Immune Cell Storage Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neonatal Immune Cell Storage Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neonatal Immune Cell Storage Service market.

Neonatal Immune Cell Storage Service Segment by Company

Shanghai Cell Therapy Group

BGI Group

VCANBIO

CGT GLOBAL

Cordlife Group

ThermoGenesis

HealthBanks

BioLife Solutions

Sartorius

CGT GLOBAL

Cordlife Group

Aeterna Health

Cell Vault

Redermis

Innovita Research

Neonatal Immune Cell Storage Service Segment by Type

100ml Blood Collection Volume

150ml Blood Collection Volume

200ml Blood Collection Volume

Neonatal Immune Cell Storage Service Segment by Application

Personal

Commercial

Neonatal Immune Cell Storage Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neonatal Immune Cell Storage Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neonatal Immune Cell Storage Service key companies, revenue, market share, and recent developments.

3. To split the Neonatal Immune Cell Storage Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neonatal Immune Cell Storage Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neonatal Immune Cell Storage Service significant trends, drivers, influence factors in global and regions.

6. To analyze Neonatal Immune Cell Storage Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Immune Cell Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neonatal Immune Cell Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Immune Cell Storage Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neonatal Immune Cell Storage Service industry.

Chapter 3: Detailed analysis of Neonatal Immune Cell Storage Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neonatal Immune Cell Storage Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neonatal Immune Cell Storage Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neonatal Immune Cell Storage Service Industry Trends Table 2. Neonatal Immune Cell Storage Service Industry Drivers Table 3. Neonatal Immune Cell Storage Service Industry Opportunities and Challenges Table 4. Neonatal Immune Cell Storage Service Industry Restraints Table 5. Global Neonatal Immune Cell Storage Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neonatal Immune Cell Storage Service Revenue Share by Company (2021-2026) Table 7. Global Neonatal Immune Cell Storage Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neonatal Immune Cell Storage Service Key Company Manufacturing Base & Headquarters Table 9. Global Neonatal Immune Cell Storage Service Company, Product Type & Application Table 10. Global Neonatal Immune Cell Storage Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neonatal Immune Cell Storage Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 100ml Blood Collection Volume Table 15. Significant Companies of 150ml Blood Collection Volume Table 16. Significant Companies of 200ml Blood Collection Volume Table 17. Global Neonatal Immune Cell Storage Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Neonatal Immune Cell Storage Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Neonatal Immune Cell Storage Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Neonatal Immune Cell Storage Service Sales Value Share by Type (2021-2026) Table 21. Global Neonatal Immune Cell Storage Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Personal Table 23. Significant Companies of Commercial Table 24. Global Neonatal Immune Cell Storage Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Neonatal Immune Cell Storage Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Neonatal Immune Cell Storage Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Neonatal Immune Cell Storage Service Sales Value Share by Application (2021-2026) Table 28. Global Neonatal Immune Cell Storage Service Sales Value Share by Application (2027-2032) Table 29. Global Neonatal Immune Cell Storage Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Neonatal Immune Cell Storage Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Neonatal Immune Cell Storage Service Sales Value Share by Region (2021-2026) Table 32. Global Neonatal Immune Cell Storage Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Neonatal Immune Cell Storage Service Sales Value Share by Region (2027-2032) Table 34. Global Neonatal Immune Cell Storage Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Neonatal Immune Cell Storage Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Neonatal Immune Cell Storage Service Sales Value Market Share by Country (2021-2026) Table 37. Global Neonatal Immune Cell Storage Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Neonatal Immune Cell Storage Service Sales Value Market Share by Country (2027-2032) Table 39. Shanghai Cell Therapy Group Company Information Table 40. Shanghai Cell Therapy Group Business Overview Table 41. Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Product Portfolio Table 43. Shanghai Cell Therapy Group Recent Development Table 44. BGI Group Company Information Table 45. BGI Group Business Overview Table 46. BGI Group Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. BGI Group Neonatal Immune Cell Storage Service Product Portfolio Table 48. BGI Group Recent Development Table 49. VCANBIO Company Information Table 50. VCANBIO Business Overview Table 51. VCANBIO Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. VCANBIO Neonatal Immune Cell Storage Service Product Portfolio Table 53. VCANBIO Recent Development Table 54. CGT GLOBAL Company Information Table 55. CGT GLOBAL Business Overview Table 56. CGT GLOBAL Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio Table 58. CGT GLOBAL Recent Development Table 59. Cordlife Group Company Information Table 60. Cordlife Group Business Overview Table 61. Cordlife Group Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio Table 63. Cordlife Group Recent Development Table 64. ThermoGenesis Company Information Table 65. ThermoGenesis Business Overview Table 66. ThermoGenesis Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ThermoGenesis Neonatal Immune Cell Storage Service Product Portfolio Table 68. ThermoGenesis Recent Development Table 69. HealthBanks Company Information Table 70. HealthBanks Business Overview Table 71. HealthBanks Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. HealthBanks Neonatal Immune Cell Storage Service Product Portfolio Table 73. HealthBanks Recent Development Table 74. BioLife Solutions Company Information Table 75. BioLife Solutions Business Overview Table 76. BioLife Solutions Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. BioLife Solutions Neonatal Immune Cell Storage Service Product Portfolio Table 78. BioLife Solutions Recent Development Table 79. Sartorius Company Information Table 80. Sartorius Business Overview Table 81. Sartorius Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sartorius Neonatal Immune Cell Storage Service Product Portfolio Table 83. Sartorius Recent Development Table 84. CGT GLOBAL Company Information Table 85. CGT GLOBAL Business Overview Table 86. CGT GLOBAL Neonatal Immune Cell Storage Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio Table 88. CGT GLOBAL Recent Development Table 89. Cordlife Group Company Information Table 90. Cordlife Group Business Overview Table 91. Cordlife Group Neonatal Immune Cell Storage Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio Table 93. Cordlife Group Recent Development Table 94. Aeterna Health Company Information Table 95. Aeterna Health Business Overview Table 96. Aeterna Health Neonatal Immune Cell Storage Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Aeterna Health Neonatal Immune Cell Storage Service Product Portfolio Table 98. Aeterna Health Recent Development Table 99. Cell Vault Company Information Table 100. Cell Vault Business Overview Table 101. Cell Vault Neonatal Immune Cell Storage Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Cell Vault Neonatal Immune Cell Storage Service Product Portfolio Table 103. Cell Vault Recent Development Table 104. Redermis Company Information Table 105. Redermis Business Overview Table 106. Redermis Neonatal Immune Cell Storage Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Redermis Neonatal Immune Cell Storage Service Product Portfolio Table 108. Redermis Recent Development Table 109. Innovita Research Company Information Table 110. Innovita Research Business Overview Table 111. Innovita Research Neonatal Immune Cell Storage Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Innovita Research Neonatal Immune Cell Storage Service Product Portfolio Table 113. Innovita Research Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Neonatal Immune Cell Storage Service Product Image Figure 2. Global Neonatal Immune Cell Storage Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neonatal Immune Cell Storage Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Neonatal Immune Cell Storage Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 100ml Blood Collection Volume Image Figure 8. 150ml Blood Collection Volume Image Figure 9. 200ml Blood Collection Volume Image Figure 10. Global Neonatal Immune Cell Storage Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Neonatal Immune Cell Storage Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Neonatal Immune Cell Storage Service Sales Value Share by Type (2021-2032) Figure 13. Personal Image Figure 14. Commercial Image Figure 15. Global Neonatal Immune Cell Storage Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Neonatal Immune Cell Storage Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Neonatal Immune Cell Storage Service Sales Value Share by Application (2021-2032) Figure 18. Global Neonatal Immune Cell Storage Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Neonatal Immune Cell Storage Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Neonatal Immune Cell Storage Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Neonatal Immune Cell Storage Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Neonatal Immune Cell Storage Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Neonatal Immune Cell Storage Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Neonatal Immune Cell Storage Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Neonatal Immune Cell Storage Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Neonatal Immune Cell Storage Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Neonatal Immune Cell Storage Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Neonatal Immune Cell Storage Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Neonatal Immune Cell Storage Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • 100ml Blood Collection Volume
  • 150ml Blood Collection Volume
  • 200ml Blood Collection Volume
Applications
  • Personal
  • Commercial
Companies covered
  • Shanghai Cell Therapy Group
  • BGI Group
  • VCANBIO
  • CGT GLOBAL
  • Cordlife Group
  • ThermoGenesis
  • HealthBanks
  • BioLife Solutions
  • Sartorius
  • CGT GLOBAL
  • Cordlife Group
  • Aeterna Health
  • Cell Vault
  • Redermis
  • Innovita Research

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neonatal Immune Cell Storage Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neonatal Immune Cell Storage Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neonatal Immune Cell Storage Service Market Dynamics
  1. 2.1 Neonatal Immune Cell Storage Service Industry Trends
  2. 2.2 Neonatal Immune Cell Storage Service Industry Drivers
  3. 2.3 Neonatal Immune Cell Storage Service Industry Opportunities and Challenges
  4. 2.4 Neonatal Immune Cell Storage Service Industry Restraints
3 Neonatal Immune Cell Storage Service Market by Company
  1. 3.1 Global Neonatal Immune Cell Storage Service Company Revenue Ranking in 2025
  2. 3.2 Global Neonatal Immune Cell Storage Service Revenue by Company (2021-2026)
  3. 3.3 Global Neonatal Immune Cell Storage Service Company Ranking (2024-2026)
  4. 3.4 Global Neonatal Immune Cell Storage Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Neonatal Immune Cell Storage Service Company Product Type and Application
  6. 3.6 Global Neonatal Immune Cell Storage Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neonatal Immune Cell Storage Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neonatal Immune Cell Storage Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neonatal Immune Cell Storage Service Market by Type
  1. 4.1 Neonatal Immune Cell Storage Service Type Introduction
  2. 4.1.1 100ml Blood Collection Volume
  3. 4.1.2 150ml Blood Collection Volume
  4. 4.1.3 200ml Blood Collection Volume
  5. 4.2 Global Neonatal Immune Cell Storage Service Sales Value by Type
  6. 4.2.1 Global Neonatal Immune Cell Storage Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Neonatal Immune Cell Storage Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Neonatal Immune Cell Storage Service Sales Value Share by Type (2021-2032)
5 Neonatal Immune Cell Storage Service Market by Application
  1. 5.1 Neonatal Immune Cell Storage Service Application Introduction
  2. 5.1.1 Personal
  3. 5.1.2 Commercial
  4. 5.2 Global Neonatal Immune Cell Storage Service Sales Value by Application
  5. 5.2.1 Global Neonatal Immune Cell Storage Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Neonatal Immune Cell Storage Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Neonatal Immune Cell Storage Service Sales Value Share by Application (2021-2032)
6 Neonatal Immune Cell Storage Service Regional Value Analysis
  1. 6.1 Global Neonatal Immune Cell Storage Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neonatal Immune Cell Storage Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neonatal Immune Cell Storage Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neonatal Immune Cell Storage Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neonatal Immune Cell Storage Service Sales Value (2021-2032)
  7. 6.3.2 North America Neonatal Immune Cell Storage Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neonatal Immune Cell Storage Service Sales Value (2021-2032)
  10. 6.4.2 Europe Neonatal Immune Cell Storage Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neonatal Immune Cell Storage Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neonatal Immune Cell Storage Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neonatal Immune Cell Storage Service Sales Value (2021-2032)
  16. 6.6.2 South America Neonatal Immune Cell Storage Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neonatal Immune Cell Storage Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neonatal Immune Cell Storage Service Sales Value Share by Country, 2025 VS 2032
7 Neonatal Immune Cell Storage Service Country-level Value Analysis
  1. 7.1 Global Neonatal Immune Cell Storage Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neonatal Immune Cell Storage Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neonatal Immune Cell Storage Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neonatal Immune Cell Storage Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neonatal Immune Cell Storage Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neonatal Immune Cell Storage Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neonatal Immune Cell Storage Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Cell Therapy Group
  2. 8.1.1 Shanghai Cell Therapy Group Company Information
  3. 8.1.2 Shanghai Cell Therapy Group Business Overview
  4. 8.1.3 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Product Portfolio
  6. 8.1.5 Shanghai Cell Therapy Group Recent Developments
  7. 8.2 BGI Group
  8. 8.2.1 BGI Group Company Information
  9. 8.2.2 BGI Group Business Overview
  10. 8.2.3 BGI Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BGI Group Neonatal Immune Cell Storage Service Product Portfolio
  12. 8.2.5 BGI Group Recent Developments
  13. 8.3 VCANBIO
  14. 8.3.1 VCANBIO Company Information
  15. 8.3.2 VCANBIO Business Overview
  16. 8.3.3 VCANBIO Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 VCANBIO Neonatal Immune Cell Storage Service Product Portfolio
  18. 8.3.5 VCANBIO Recent Developments
  19. 8.4 CGT GLOBAL
  20. 8.4.1 CGT GLOBAL Company Information
  21. 8.4.2 CGT GLOBAL Business Overview
  22. 8.4.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
  24. 8.4.5 CGT GLOBAL Recent Developments
  25. 8.5 Cordlife Group
  26. 8.5.1 Cordlife Group Company Information
  27. 8.5.2 Cordlife Group Business Overview
  28. 8.5.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
  30. 8.5.5 Cordlife Group Recent Developments
  31. 8.6 ThermoGenesis
  32. 8.6.1 ThermoGenesis Company Information
  33. 8.6.2 ThermoGenesis Business Overview
  34. 8.6.3 ThermoGenesis Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ThermoGenesis Neonatal Immune Cell Storage Service Product Portfolio
  36. 8.6.5 ThermoGenesis Recent Developments
  37. 8.7 HealthBanks
  38. 8.7.1 HealthBanks Company Information
  39. 8.7.2 HealthBanks Business Overview
  40. 8.7.3 HealthBanks Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HealthBanks Neonatal Immune Cell Storage Service Product Portfolio
  42. 8.7.5 HealthBanks Recent Developments
  43. 8.8 BioLife Solutions
  44. 8.8.1 BioLife Solutions Company Information
  45. 8.8.2 BioLife Solutions Business Overview
  46. 8.8.3 BioLife Solutions Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioLife Solutions Neonatal Immune Cell Storage Service Product Portfolio
  48. 8.8.5 BioLife Solutions Recent Developments
  49. 8.9 Sartorius
  50. 8.9.1 Sartorius Company Information
  51. 8.9.2 Sartorius Business Overview
  52. 8.9.3 Sartorius Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sartorius Neonatal Immune Cell Storage Service Product Portfolio
  54. 8.9.5 Sartorius Recent Developments
  55. 8.10 CGT GLOBAL
  56. 8.10.1 CGT GLOBAL Company Information
  57. 8.10.2 CGT GLOBAL Business Overview
  58. 8.10.3 CGT GLOBAL Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
  60. 8.10.5 CGT GLOBAL Recent Developments
  61. 8.11 Cordlife Group
  62. 8.11.1 Cordlife Group Company Information
  63. 8.11.2 Cordlife Group Business Overview
  64. 8.11.3 Cordlife Group Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
  66. 8.11.5 Cordlife Group Recent Developments
  67. 8.12 Aeterna Health
  68. 8.12.1 Aeterna Health Company Information
  69. 8.12.2 Aeterna Health Business Overview
  70. 8.12.3 Aeterna Health Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aeterna Health Neonatal Immune Cell Storage Service Product Portfolio
  72. 8.12.5 Aeterna Health Recent Developments
  73. 8.13 Cell Vault
  74. 8.13.1 Cell Vault Company Information
  75. 8.13.2 Cell Vault Business Overview
  76. 8.13.3 Cell Vault Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cell Vault Neonatal Immune Cell Storage Service Product Portfolio
  78. 8.13.5 Cell Vault Recent Developments
  79. 8.14 Redermis
  80. 8.14.1 Redermis Company Information
  81. 8.14.2 Redermis Business Overview
  82. 8.14.3 Redermis Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Redermis Neonatal Immune Cell Storage Service Product Portfolio
  84. 8.14.5 Redermis Recent Developments
  85. 8.15 Innovita Research
  86. 8.15.1 Innovita Research Company Information
  87. 8.15.2 Innovita Research Business Overview
  88. 8.15.3 Innovita Research Neonatal Immune Cell Storage Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Innovita Research Neonatal Immune Cell Storage Service Product Portfolio
  90. 8.15.5 Innovita Research Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst